There are two types of lung diseases: obstructive lung disease and restrictive lung disease. Both types can cause symptoms like shortness of breath, but a key difference is when you feel like you’re ...
If you're looking for a dependable and affordable laptop for everyday tasks, a device with an Intel Core i3 processor could be an excellent choice. Core i3 laptops offer a great balance of ...
Lung cancer symptoms can mimic other conditions and are easy to ignore, especially in the early stages. If you have persistent symptoms like cough, bloody phlegm, chest pain, and shortness of breath, ...
Lung received a bachelor's degree from Regis University in 1992 and a J.D. from the University of Dayton School of Law in 1997. From 2003 to 2016, he was a district court magistrate in the 18th ...
Intel has rebranded its Core i3 (and i5 and i7) line-up, ditching the iconic 'i' it's used for 16 years. It doesn’t change our advice, though. These chips are good for light work, and can easily ...
Credit-builder cards are suitable for those who have a limited credit history or struggle with debt and are keen to boost their credit score. The Aqua Classic card (representative 34.9% APR variable) ...
Intel Processor N150, Processor N250, and Core i3-N355 new Alder Lake-N processors have recently shown up in the upcoming ASUS NUC 14 Essential mini PCs and offer a small performance boost compared to ...
Amgen is discontinuing a lung disease program after its investigational small molecule failed to hit any of the primary or secondary endpoints in a midstage study. The asset at play is ...
For the last five years, Vicky Ni has been battling lung cancer — a diagnosis that came out of the blue in 2019 after she went to a doctor for pain in her shoulder. "He was taking X-rays of my ...
An abnormal BMI in children -- be it high or low -- can now be associated with impaired lung function, but if their BMI is normalized before they reach adulthood, the impairment can be offset ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Neuvivo, a late-clinical stage biopharmaceutical company, today announced promising results from two groundbreaking publications on its investigational ...